Precision Medicine & Functional Genomics 2017

(Third Annual Functional Genomics Symposium)
Theme: Towards Precision Medicine
Dates: 11–13 December 2017
Venue: St. Regis Hotel, Doha, Qatar

Overview

Precision Medicine & Functional Genomics 2017 marked the third annual gathering of international leaders in genomics, translational medicine, and clinical innovation. Organized by Sidra Medicine and co-hosted with Nature Genetics, the symposium focused on accelerating the integration of genomic discoveries into precision healthcare solutions.

The conference brought together clinicians, researchers, policymakers, and academic leaders to explore advances in genome sequencing, disease modeling, rare disease diagnostics, and emerging therapeutic strategies. Particular emphasis was placed on translating genomic research into improved outcomes for women and children in Qatar and globally.

The 2017 program reflected Sidra Medicine’s commitment to advancing precision medicine within the framework of Qatar National Vision 2030 and the Qatar Genome initiatives.

Scientific Themes

PMFG 2017 centered around key pillars shaping the future of precision healthcare:

• Large-scale genome sequencing and population genomics
• Functional validation of genetic variants
• Rare disease diagnosis and gene discovery
• Translational genomics and therapeutic innovation
• Cancer genomics and molecular pathology
• Ethical, legal, and social implications of genomic medicine

Program Highlights

The three-day scientific program featured keynote lectures, plenary sessions, and moderated panel discussions led by internationally recognized experts.

Highlights included:

• Advances in population genomics and large cohort studies
• Functional genomics approaches to understanding disease mechanisms
• Innovations in gene therapy and precision therapeutics
• Case studies in rare and undiagnosed disease programs
• Ethical frameworks guiding responsible genomic implementation

Interactive sessions encouraged multidisciplinary dialogue between laboratory scientists and frontline clinicians, reinforcing the bridge between discovery and patient care.

Learning Objectives

At the conclusion of the conference, participants were able to:

• Identify diseases and disorders that benefit from genomic diagnosis and precision medicine strategies
• Discuss functional genomics tools used to interpret disease-causing variants
• Recognize emerging therapeutic approaches informed by genomic discovery
• Understand the importance of population genomics initiatives in Qatar and globally
• Evaluate ethical considerations in genomic data implementation

Target Audience

The symposium was designed for:

• Physicians and clinical specialists
• Researchers in genomics and molecular medicine
• Genetic counselors
• Pharmacists and allied health professionals
• Biomedical scientists and bioinformaticians
• Healthcare policymakers and academic faculty

Accreditation

The conference was accredited as a Category 1 Continuing Professional Development (CPD) activity in accordance with relevant regulatory standards.

The Scientific Planning Committee reviewed all disclosed financial relationships in advance of the activity and implemented procedures to manage any potential or real conflicts of interest.

Legacy and Impact

PMFG 2017 strengthened Qatar’s position as a regional hub for precision medicine dialogue and collaboration. The symposium fostered international partnerships and reinforced Sidra Medicine’s leadership in genomic medicine research and clinical translation.

By convening global experts alongside regional leaders, the 2017 meeting contributed to shaping the roadmap for precision medicine implementation in the Middle East